667, L.P.

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2026-04-23	2026-04-23	Protara Therapeutics Inc (TARA)	PrS Proposed sale	79,181 252.18 US$1,822,424	79,181	252.18	US$1,822,424
2026-03-06	2026-03-06	Protara Therapeutics Inc (TARA)	PrS Proposed sale	33,763 268.21 US$561,667	33,763	268.21	US$561,667
2026-03-04	2026-03-04	Protara Therapeutics Inc (TARA)	PrS Proposed sale	20,919 487.29 US$2,030,132	20,919	487.29	US$2,030,132
2026-02-25	2026-02-25	Protara Therapeutics Inc (TARA)	PrS Proposed sale	78,716 5.81 US$457,046	78,716	5.81	US$457,046
2026-02-24	2026-02-24	Protara Therapeutics Inc (TARA)	PrS Proposed sale	26,755 6.04 US$161,584	26,755	6.04	US$161,584
2025-02-28	2025-02-28	BeOne Medicines AG (688235)	PrS Proposed sale	60,851 260.00 US$15,821,260	60,851	260.00	US$15,821,260
2024-12-09	2024-12-09	BeOne Medicines AG (688235)	PrS Proposed sale	86,110 187.27 US$16,125,648	86,110	187.27	US$16,125,648
2023-11-14	2023-11-14	BeOne Medicines AG (688235)	PrS Proposed sale	91,340 198.85 US$18,162,959	91,340	198.85	US$18,162,959